|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-18
|
|
pubmed:abstractText |
Our previous studies have demonstrated that GAD-IgG-transduced splenocytes protect non-obese diabetic (NOD) mice from diabetes by in vitro-inducing CD4(+)Foxp3(+)Treg cells. However, the underlying mechanisms by which CD4(+)Foxp3(+)Treg cells suppress diabetes remain unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0188-4409
|
|
pubmed:author |
pubmed-author:ChenGuojiangG,
pubmed-author:HanGenchengG,
pubmed-author:LiYanY,
pubmed-author:QianJiahuaJ,
pubmed-author:ShenBeifenB,
pubmed-author:ShyuH YHY,
pubmed-author:WangJiananJ,
pubmed-author:WangRenxiR,
pubmed-author:XuRuonanR,
pubmed-author:YuMingM,
pubmed-author:ZhangChunmeiC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
299-305
|
|
pubmed:meshHeading |
pubmed-meshheading:18279702-Animals,
pubmed-meshheading:18279702-Antigens, CD80,
pubmed-meshheading:18279702-Antigens, CD86,
pubmed-meshheading:18279702-Diabetes Mellitus,
pubmed-meshheading:18279702-Female,
pubmed-meshheading:18279702-Forkhead Transcription Factors,
pubmed-meshheading:18279702-Glutamate Decarboxylase,
pubmed-meshheading:18279702-Immune Tolerance,
pubmed-meshheading:18279702-Immunoglobulin G,
pubmed-meshheading:18279702-Mice,
pubmed-meshheading:18279702-Mice, Inbred NOD,
pubmed-meshheading:18279702-Peptide Fragments,
pubmed-meshheading:18279702-T-Lymphocytes, Regulatory,
pubmed-meshheading:18279702-Up-Regulation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
GAD-IgG-inducing CD4+Foxp3+Treg cells suppressing diabetes are involved in the increasing ratio of CD80+:CD86+ CELLS in NOD mice.
|
|
pubmed:affiliation |
Department of Molecular Immunology, Institute of Basic Medical Sciences, Beijing, PR China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
